DiaMedica Therapeutics In...

NASDAQ: DMAC · Real-Time Price · USD
6.03
0.02 (0.33%)
At close: Aug 15, 2025, 3:59 PM
6.03
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT

DiaMedica Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
39K 30K 25K 24K
Gross Profit
-39K -30K -25K -24K
Operating Income
-26.68M -21.27M -14M -13.65M
Interest Income
2.3M n/a n/a n/a
Pretax Income
-24.41M -19.34M -13.65M -13.56M
Net Income
-24.44M -19.38M -13.68M -13.59M
Selling & General & Admin
7.62M 8.16M 6.16M 4.88M
Research & Development
19.06M 13.11M 7.84M 8.77M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
26.68M 21.27M 14M 13.65M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
26.68M 21.27M 14M 13.65M
Income Tax Expense
30K 43K 28K 28K
Shares Outstanding (Basic)
40.4M 32.57M 26.44M 20.77M
Shares Outstanding (Diluted)
40.4M 32.57M 26.44M 20.77M
EPS (Basic)
-0.6 -0.6 -0.52 -0.65
EPS (Diluted)
-0.6 -0.6 -0.52 -0.65
EBITDA
-24.38M -19.31M -13.98M -13.62M
EBIT
-24.41M -19.34M -13.65M -13.56M
Depreciation & Amortization
39K 30K 25K 24K